Cancer News: Generic
Cancer and people with mental illness
A new report provides evidence and key recommendations for medical clinicians to improve cancer prevention and treatment of people with mental illness.
U.S. approval of an antidote for chemotherapy overdosing
U.S. regulators approved the drug uridine triacetate (Vistogard) for the treatment of overdoses of the chemotherapy drugs fluorouracil and capecitabine.
Sharing symptoms online boosts cancer patients’ survival
Cancer patients who shared their symptoms online improved their quality of life and stayed on treatment longer, a new research points out.
Anxious about getting a genetic cancer screening?
Counseling before and after a genetic cancer screening helped BRCA 1/2-negative patients make informed decisions and deal with anxiety, a new research reveals.
Warfarin: an acceptable treatment for cancer-associated thrombosis
Warfarin can be used for the long-term treatment of cancer-associated thrombosis, in place of standard treatment low-molecular-weight heparin, a new study suggests.
Regardless of treatment, cancer doesn’t always go away
A new meta-analysis study reveals that complete response rate to chemotherapy treatment remain low to common types of late-stage cancer despite of new treatment methods.
What challenges do survivors of childhood or young adult cancer face?
Two recent clinical studies shed light on the health challenges faced by survivors of childhood or young adult cancer.
Pancreatic cancer immunotherapy shows promise in melanoma
According to latest five year survival clinical results, patients with metastatic melanoma were benefited by IMM-101, a pancreatic cancer immunotherapy drug.
Psychological factors and nausea during cancer therapy
A new study reveals the relationship between psychological factors and nausea and vomiting during chemotherapy of cancer.
A constipation drug extends survival in advanced cancer patients
Methylnaltrexone, a drug approved to treat opioid-induced constipation showed promise when administered to advanced cancer patients, a new study reveals.
Steroid use for less pain flare in patients with bone metastasis
Cancer patients with painful bone metastases experienced fewer and less severe radiation-induced pain flare episodes with the steroid dexamethasone.
Dietary habits of cancer survivors linked to their long-term health
A new study sheds light on the dietary habits of cancer survivors pointing out the need for dietary interventions in order to prevent a variety of health problems.
Prenatal exposure to cancer treatment: is it dangerous for the baby?
Children born to mothers affected by cancer had no significant differences in mental development compared to children from the general population.
Exercise after a cancer diagnosis to extend survival
A new analysis of 70 existing studies revealed that in patients diagnosed with cancer, physical activity extended survival rates.
More therapeutic options against nausea and vomiting from chemotherapy
Tesaro’s Varubi got approved by the FDA for the prevention of delayed phase chemotherapy-induced nausea and vomiting.
Can alternative medicine compromise the efficacy of cancer drugs?
Senior oncology patients often use alternative medications together with their cancer treatment without knowing the potential drug-drug interactions.
Understanding the link between cancer and metabolism
Given the absence of scientific evidence relating cancer and food, experts have created four articles describing cancer and obesity, antioxidants and biomarkers.
Potential harm of chemotherapy in patients with end-stage cancer
A study reveals that for patients with end-stage cancer, still able to perform many life functions, chemotherapy worsened their quality of life.
Vitamin D and weight loss to reduce inflammation linked to cancer
Combining weight loss with vitamin D had better results in reducing chronic inflammation. Chronic inflammation is linked to the development of some cancers.
Drug for common cancer treatment side-effects gets EU approval
The drug Akynzeo® gained European approval for the prevention of chemotherapy induced nausea and vomiting (CINV).
Stress relief techniques against fear of cancer treatment
Cancer patients who experience stress and fear of treatment both before and during interventions reduced their stress levels by using stress-relief techniques, a new study shows.
Daily aspirin may help prevent gastrointestinal cancers
Taking aspirin regularly and for a long time may decrease the risk of gastrointestinal cancer. However, the potential risks of prolonged aspirin use should be considered.
Improving the quality of life in cancer survivors through nutrition
A new online tool promotes better nutrition practices in cancer survivors, and helps them improve their quality of life and prevent future relapses.
Green tea and apples against chronic diseases
Certain compounds found naturally in foods such as green tea and apples have been found to help prevent chronic diseases, a new study says.
Higher coffee consumption may protect against liver cancer
A study focused on coffee, alcohol and liver cancer, showing that regular coffee intake could reduce liver cancer risk caused by daily alcohol consumption.
A familial connection between breast and prostate cancer
Having first-degree relatives with a history of prostate cancer increases a woman’s risk of developing breast cancer, according to a new study.
Could a gene link lung cancer with Parkinson's disease?
A gene mutation, previously related with early-onset Parkinson's disease, was found to be associated with lung cancer.
Your cancer is not a just matter of “bad luck”
Scientists disapprove of a new study which supports the idea that bad luck is to blame for cancer, more than hereditary or external environmental factors.
Details of DNA damaged by smoking under research
Researchers have succeeded in amplifying genes altered by activities possibly causing lung cancer such as smoking, enabling deeper analysis of cancer causes.
Preventing clot recurrence in cancer patients: heparin vs warfarin
A study confirms that patients getting low-molecular-weight heparin are better protected against recurrence of clots (deep-vein thrombosis) compared to warfarin